Ahmed AR, Lappin D. Oral alkali therapy and the management of metabolic acidosis of chronic kidney disease: A narrative literature review. World J Nephrol. 2018;7(6):117-22 Länk till annan webbplats, öppnas i nytt fönster..
Goraya N, Wesson DE. Management of the Metabolic Acidosis of Chronic Kidney Disease. Adv Chronic Kidney Dis. 2017;24(5):298-304 Länk till annan webbplats, öppnas i nytt fönster..
Hu MK, Witham MD, Soiza, RL. Oral Bicarbonate Therapy in Non-Haemodialysis Dependent Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Clin. Med. 2019, 8, 208 Länk till annan webbplats, öppnas i nytt fönster.. Fulltext Länk till annan webbplats.
Dubey AK, Sahoo J, Vairappan B, Haridasan S, Parameswaran S, Priyamvada PS. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial. Nephrol Dial Transplant. 2020;35(1):121-9 Länk till annan webbplats, öppnas i nytt fönster..
Gaggl M, Repitz A, Riesenhuber S, Aigner C, Sliber C, Fraunschiel M, Cejka D, Sunder-Plassmann G. Effect of Oral Sodium Bicarbonate Treatment on 24-Hour Ambulatory Blood Pressure Measurements in Patients With Chronic Kidney Disease and Metabolic Acidosis. Front Med (Lausanne). 2021 Sep 6;8:711034. Länk till annan webbplats.
Hultin S, Hood C, Campbell KL, Toussaint ND, Johnson DW, Badve SV. A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes. Kidney Int Rep. 2020 Dec 31;6(3):695-705 Länk till annan webbplats.
Shi H, Su X, Yan B, Li C, Wang L. Effects of orala alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: asystematic review and meta-analysis. Renal failure. 2022, vol 44 (1), 106-115 Länk till annan webbplats..

Metabol acidos